Postoperative nausea and vomiting in patients undergoing elective laparoscopic sleeve gastrectomy
Conditions
Interventions
Con:Continuous intravenous infusion of 0.9% normal saline
Dex:Continuous intravenous infusion of dexmedetomidine
TEAS:Intervention with the transcutaneous electrical acupoint stimulation at Neiguan point (PC6) and Zusanli point (ST36)
TEAS+Dex:Intervention with the TEAS at Neiguan and Zusanli point combined with Continuous intravenous infusion of dexmedetomidine
Sponsors
Capital Medical University, Beijing Shijitan Hospital
Eligibility
Sex/Gender
All
Age
16 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1 Age 16-65 years old; 2 ASA Grade I to III; 3 Voluntary informed consent
Exclusion criteria
Exclusion criteria: 1 transcutaneous electrical acupoint stimulation is contraindicated, including local skin damage, infection or electrophysiological devices implanted in the body; 2 Communication disorders, unable to cooperate with researchers; 3 Patients with myocardial infarction or cerebral infarction within half a year and patients with heart failure within 1 month; 4 long-term use of hormones or antiemetic drugs; 5 Patients with slow ventricular rate, sick sinus syndrome and preexcitation syndrome; 6 Patients with degree II and above atrioventricular block; 7 those who have taken opioids in the last 3 months; 8 Liver and kidney insufficiency; 9 Participants in other clinical trials within 3 months prior to study enrollment; 10 Other situations that researchers deem unsuitable for inclusion..
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative nausea and vomiting; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative nausea and vomiting;Postoperative pain score; Perioperative sufentanil, remifentanil dosage;Serum Serum motilin, serotonin levels;Postoperative complications; | — |
Countries
China
Contacts
Public ContactPengfei Liu
Capital Medical University, Beijing Shijitan Hospital
Outcome results
None listed